Shilpa Medicare files patent infringement suit against Novartis over Fingolimod Medical Dialogues Team29 April 2021 11:00 AM ISTNew Delhi: In a setback to Novartis Pharmaceutical Corporation, Shilpa Pharma inc, a Shilpa Medicare subsidiary headquartered in the United States,...
Shilpa Medicare can make 200 million Covid-19 vaccine doses, says Executive Ruchika Sharma8 April 2021 12:00 PM ISTBengaluru: Indian drugmaker Shilpa Medicare Ltd has the capacity to manufacture 100-200 million doses of a protein-based vaccine for COVID-19, a...
Shilpa Medicare gets USFDA nod for psoriatic arthritis drug Apremilast Ruchika Sharma6 March 2021 11:35 AM ISTKarnataka: Shilpa Medicare has recently announced that the company has received U.S Food and Drug Administration (USFDA) tentative approval for...
8 Pharma Firms including Mylan, Aurobindo Pharma to pay Rs 18.25 lakh for allegedly violating green norms MD Bureau18 Jan 2021 8:03 PM ISTHyderabad: Violation of pollution control norms has costed eight pharmaceutical units each, including Hetero Labs, Aurobindo Pharma, and Mylan...
Shilpa Medicare gets USFDA warning for CGMP violations at Telangana unit Ruchika Sharma2 Nov 2020 1:00 PM ISTThe significant violations included the company's failure to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its...
Shilpa Medicare board gives nod to establish subsidiary in Malaysia Medical Dialogues Team21 Sept 2020 9:30 AM ISTShilpa Medicare Limited has decided to establish a wholly-owned subsidiary in Malaysia for the business operations of the company. "The Board of...
Shilpa Medicare launches ready-to-drink green tea films in India Ruchika Sharma26 Aug 2020 12:21 PM ISTNew Delhi: Drug firm Shilpa Medicare on Monday said it has forayed into over-the-counter (OTC) segment with the launch of ready-to-drink green tea...
Shilpa Medicare launches generic Axitinib to treat advanced kidney cancer Ruchika Sharma2 July 2020 1:18 PM ISTAXISHIL is used to treat patients suffering from Advanced Renal Cell Carcinoma (RCC).
Shilpa Medicare to acquire FTF Pharma for Rs 75 crore, pick up 40pc stake in Auxilla Pharma for Rs 60 crore Farhat Nasim18 Jun 2020 7:18 PM ISTNew Delhi: Shilpa Medicare Ltd, recently said that it is all set to acquire FTF Pharma Private Limited while it will also pick up a 40% stake in...
Shilpa Medicare launches IBRUSHIL for Leukemia in India Ruchika Sharma29 May 2020 12:22 PM ISTIBRUSHIL is used to treat patients suffering from Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphomas (MCL), and other related cancers
Shilpa Medicare launches generic verision cancer drug Dasatinib at monthly therapy cost of Rs 6,440 Ruchika Sharma25 April 2020 12:44 PM ISTThe branded generic anti-cancer drug will be available in all dosage strengths of 20/ 50/ 70/ 100 mg tablets
Shilpa Medicare gets USFDA EIR for Raichur API Unit Ruchika Sharma21 April 2020 12:07 PM ISTRaichur: Shilpa Medicare Limited has announced the receipt of Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA)...
